A Phase II, Multicentre, Randomised, Open-Label, Parallel Group Study to Evaluate the Safety and Efficacy of Velcade® added to Thalidomide-Dexamethasone Standard Treatment in Subjects with Multiple Myeloma who are Refractory to or Have Relapsed after Primary Therapy for Multiple Myeloma to assess the safety and efficacy of adding Velcade® to thalidomide and dexamethasone (Thal-Dex) standard treatment in subjects with multiple myeloma who are refractory to or have relapsed after thei...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Comparación de fentanilo transdérmico y morfina intravenosa en analgesia controlada por el paciente para el control del dolor postoperatorio Aim of this study This study will evaluate the clinical use, safety and and ease of care of a Transdermal PCA system and morphine IV PCA for management of moderate to severe acute pain in post?operati...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Velcade bone trial The primary objective is to assess the effect of bortezomib on myeloma related bone disease by analyzing bone mineral density (BMD).

• Pays Aucun
• Organes Aucun
• Spécialités Aucune